1. The intra-arterial blood pressure responses to Valsalva's manoeuvre and postural change were investigated as indices of cardiovascular reflex activity in seventeen Parkinsonian patients on maximally tolerated doses of L( -)-dopa (levodopa) and repeated in nine patients on levodopa with an extracerebral decarboxylase inhibitor, L-alpha methyldopahydrazine. The results were compared with control pretreatment responses.
It has been claimed that the blood pressure in untreated Parkinsonism is lower than in the normal population (Barbeau, Gillo-Joffroy, Boucher, Nowaczynski & Genest, 1969) and others have drawn attention to the finding of autonomic disturbances in these patients (McDowel1 & Lee, 1970; Appenzeller & GOSS, 1971) . However, the deterioration in baroreceptor reflex activity seen in Parkinsonism can be accounted for by the impairment which normally takes place with advancing age (Reid, Calne, George, Pallis & Vakil, 1971) . Aminoff & Wilcox (1971) and Gross, Bannister & Godwin-Austen (1972) also found that baroreflex function measured by the response to Valsalva's manoeuvre is normal in Parkinsonian patients although the latter did observe significantly greater decreases in pressure on head-up tilting than in age-matched controls.
The cause of hypotension induced by levodopa is uncertain. Mechanisms within the central nervous system similar to those proposed to account for the hypotensive action of L-alpha methyldopa (Henning & Rubenson, 1970 ) may be involved, but there is also evidence that levodopa interferes with neurotransmission in peripheral adrenergic nerves (Whitsett, Halushka & Goldberg, 1970) .
Levodopa itself is pharmacologically inert, achieving its biological activity after decarboxylation, by L-aromatic aminoacid decarboxylase, to the catecholamines. L-Aromatic aminoacid decarboxylase is inhibited by L-alpha methyldopahydrazine, a drug that does not penetrate the blood-brain barrier. L-Alpha methyldopahydrazine has been used clinically in combination with levodopa to diminish the peripheral side effects of levodopa caused by excessive extracerebral catecholamines (Calne, Reid, Vakil, Rao, Petrie, Pallis, Gawler, Thomas & Hilson, 1971 ; Cotzias et al., 1969; Papavasiliou, Cotzias, Duby, Steck, Fehling & Bell, 1972) .
We have investigated the action of levodopa on the cardiovascular response to Valsalva's manoeuvre and postural change in Parkinsonian patients with and without extracerebral decarboxylase inhibition by L-alpha methyldopahydrazine. In this way we have attempted to distinguish between central and peripheral actions of levodopa on circulatory control.
P A T I E N T S A N D M E T H O D S
Seventeen Parkinsonian patients were studied, whose ages ranged from 36 to 69 years; there were nine men and eight women. The cardiovascular reflexes in all patients had previously been studied before starting treatment with levodopa . Fifteen of the patients were taking conventional anticholinergic antiparkinsonian drugs, the doses of which were not altered.
Studies were performed after 2-9 months on maximum tolerated doses of levodopa and repeated in nine patients after 8-10 weeks on L-alpha methyldopahydrazine (300 mg per day) given in combination with maximum tolerated doses of levodopa (Table 1) .
The intra-arterial pressures and heart-rate responses to Valsalva's manoeuvre and head-up tilt were measured as previously described ) using a femoral arterial cannula inserted under local anaesthesia. The recordings were made 1&2 h after administration of one quarter of the total daily dose of levodopa. The response to Valsalva's manoeuvre was analysed (Sharpey-Schafer, 1955; Gross, 1970; Reid et al., 1971) 
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The mean of at least two responses was taken on each occasion. The response to postural change was investigated by tilting from horizontal to 35" head-up on a motor-driven table for 2 min. The blood pressure and heart rate were compared before and after 1 min of tilt (with appropriate correction for the hydrostatic pressure in the tilted position). Mean arterial pressure was calculated as diastolic pressure plus one-third pulse pressure.
All patients gave their informed consent to the studies and no complications of arterial cannulation were encountered. 
RESULTS

Valsalva's manoeuvre
Constrictor index. The values of the constrictor index are shown in Tables 2 and 4 . The mean index decreased from 0.41 8 f 0.051 (mean f SEM) to 0.292 f 0.040 while taking levodopa alone and this reduction was statistically significant by analysis with a paired Student t-test (P < 0.01). The mean value of the constrictor index in patients taking levodopa plus L-alpha methyldopahydrazine was higher (0-471 f 0080), and not significantly different from the pretreatment values for this group (0432+0.080). In Fig. 1 the constrictor indices on both regimens are expressed as a percentage of the pretreatment values. Thus levodopa alone caused a significant deterioration in the pressor response to Valsalva's manoeuvre which was reversed when the drug was given in combination with an extracerebral decarboxylase inhibitor. Accelerator index. The mean value before treatment was 0.356+0.048 and while taking levodopa alone it was 0.355+0*040 (Tables 3 and 4) . These values were not significantly different. After addition of the extracerebral decarboxylase inhibitor the mean accelerator index was 0.416 k0.097 which was not significantly different from the values before or during treatment with levodopa alone. The mean values for blood pressure and heart rate before and after head-up tilt are shown in Horizontal values. The Student t-test showed that both treatment regimens (levodopa withand without L-alpha methyldopahydrazine) resulted in a significant reduction in the horizontal systolic (P<0.05), diastolic (P<O.OOI) and mean arterial pressure (P<O*O1). There was no significant difference between the pressures recorded on the two treatment regimens.
Head-up values. With head-up tilt, both treatment regimens resulted in a significant fall in mean arterial pressure when compared with pretreatment values ( P < 0.05 for levodopa alone; P < 0-001 for levodopa + L-alpha methyldopahydrazine). However, there was no significant difference between the values on each regimen (P> 0.05).
Tilting from the horizontal position to 35" head-up led to an increase in the mean arterial pressures before and during each treatment regimen. These increases were caused by increase of the diastolic pressure, the systolic pressures remaining essentially unchanged.
Before and during treatment the heart rate increased on tilting, but there was no difference between the two treated groups.
DISCUSSION
These results indicate that in Parkinsonian patients taking levodopa for 2-9 months the pressor response to Valsalva's manoeuvre is significantly impaired when compared to 'within patient' pretreatment controls. Similar results were reported by Appenzeller & Goss (1971) in a study of autonomic function in Parkinsonian patients which included five cases receiving levodopa. The addition of L-alpha methyldopahydrazine, a decarboxylase inhibitor whose action is limited to extracerebral tissues, caused the pressor response to return to pretreatment values. These findings indicate that the impairment of baroreflex responses induced by levodopa is mediated, at least in part, by a peripheral mechanism. Levodopa therapy does not alter the pressor sensitivity to intravenous noradrenaline or tyramine (Reid, Calne, George & Vakil, 1972) , and we concluded that levodopa does not have an action upon adrenergic receptor sensitivity or 'tyramine releasable' stores of noradrenaline. However, our observations did not exclude the possibility of a peripheral site of action for levodopa as there is evidence for the existence of a dopaminergic vasodilator mechanism in the mesenteric and renal vascular beds (McNay, McDonald & Goldberg, 1965; Hamilton, 1972) . Further, the 'tyramine releasable' pool of noradrenaline in adrenergic neurons differs from that activated by neuronal discharge (Trendelenberg, 1965) , so it is possible that physiologically releasable noradrenaline stores in sympathetic nerve endings are depleted. Previous studies have shown that dopamine can displace noradrenaline from certain storage sites (Harrison, Levitt & Udenfriend, 1963) .
The plasma concentrations of levodopa were estimated in seven of the patients in this study.
There was no significant difference in the plasma concentration of levodopa 13 h after ingestion of maximum tolerated dosage with and without L-alpha methyldopahydrazine, although the doses of levodopa had to be decreased by 80% when peripheral decarboxylase was blocked. At 3 h after ingestion, the plasma concentration of levodopa was significantly higher when taking the decarboxylase inhibitor (Allen, Calne, Davies & Reid, 1971) . Thus the effect of peripheral decarboxylase blockade on the baroreflexes cannot be attributed to decreased tissue availability of levodopa. Although there was considerable variation in the maximum concentrations of levodopa (range 0.1 5 -2 4 pg/ml), the plasma levodopa concentration did not correlate with the extent of impairment in the pressor indices. There was no detectable relationship between the Valsalva response and the dose of levodopa, the severity of Parkinsonian features, or the degree of neurological improvement. Although the responses to Valsalva's manoeuvre were impaired, none of the patients had symptoms of postural hypotension and in no patient did the systolic or mean arterial pressure decrease by more than 15 mmHg after 1 min of head-up tilt. During a double-blind crossover comparison of levodopa given with and without L-alpha methyldopahydrazine, the systolic arterial pressure (lying and standing) was significantly higher on the combined regimen than on levodopa alone (Calne, Petrie, Rao, Reid & Vakil, 1972) . These results were based on several sphygmomanometer recordings taken 'blind' over a period of 6 weeks, and agree with our observations on Valsalva's manoeuvre. Although in our current studies L-alpha methyldopahydrazine decreased the postural decrease in systolic pressure induced by levodopa, this effect was not statistically significant, perhaps because of the limited number of serial observations possible when arterial cannulation is performed. Further, the response to Valsalva's manoeuvre is probably a more sensitive index of baroreceptor reflex function than postural change.
The horizontal and mean arterial pressures were significantly lower while taking levodopa than pretreatment values. A hypotensive action is still evident after extracerebral decarboxylase inhibition. These observations suggest that levodopa may lower the blood pressure by altering brain catecholamine concentrations, quite apart from the peripheral impairment of baroreceptor reflexes. Such a central action is not surprising, in view of the accumulating evidence that neuronal sytems within the brain employ catecholamines as neurotransmitters. Fluorescent histochemical studies reveal noradrenergic neurons in the hypothalamus, medulla and the spinal cord (Dahlstrom & Fuxe, 1965) and there is increasing evidence that these play an important part in the control of autonomic function (Chalmers & Reid, 1971) .
